Cargando…

Salvaging Salvinorin: From Hallucinogen to Potential Therapeutic through Chemical Synthesis

Detalles Bibliográficos
Autores principales:	Duvvuru, Bhawyanth, Smith, Myles W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450874/ https://www.ncbi.nlm.nih.gov/pubmed/37637730 http://dx.doi.org/10.1021/acscentsci.3c00955

Ejemplares similares

The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain
por: Doss, Manoj K., et al.
Publicado: (2020)

Rapid Detection and Quantification of Hallucinogenic Salvinorin A in Commercial Salvia divinorum Products by DART-HRMS
por: Chambers, Megan I., et al.
Publicado: (2022)

Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

Quantitative determination of salvinorin A, a natural hallucinogen with abuse liability, in Internet-available Salvia divinorum and endemic species of Salvia in Taiwan
por: Lin, Po-Xiang, et al.
Publicado: (2014)

Formal Total Synthesis of Salvinorin A
por: Halang, Marc, et al.
Publicado: (2022)

Therapeutic Potential of Salvinorin A and Its Analogues in Various Neurological Disorders
por: Cichon, Joseph, et al.
Publicado: (2022)

A Non-Hallucinogenic Psychedelic Analog with Therapeutic Potential
por: Cameron, Lindsay P., et al.
Publicado: (2020)

A Protecting‐Group‐Free Synthesis of (−)‐Salvinorin A
por: Zimdars, Patrick, et al.
Publicado: (2021)

A Route to Potent, Selective, and Biased Salvinorin Chemical Space
por: Hill, Sarah J., et al.
Publicado: (2023)

The Salvinorin Analogue, Ethoxymethyl Ether Salvinorin B, Promotes Remyelination in Preclinical Models of Multiple Sclerosis
por: Paton, Kelly F., et al.
Publicado: (2021)

Is Shame Hallucinogenic?
por: McCarthy-Jones, Simon
Publicado: (2017)

Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use
por: Jones, Grant, et al.
Publicado: (2023)

Synthesis and κ-Opioid Receptor Activity of Furan-Substituted Salvinorin A Analogues
por: Riley, Andrew P., et al.
Publicado: (2014)

The Potential Role of Serotonergic Hallucinogens in Depression Treatment
por: Psiuk, Dominika, et al.
Publicado: (2021)

Unusual hemiacetal structure derived from Salvinorin A
por: Carvalho, Paulo, et al.
Publicado: (2008)

Poisonous & hallucinogenic mushrooms
por: Haard, Richard
Publicado: (1980)

Salvinorin B methoxymethyl ether
por: Munro, Thomas A., et al.
Publicado: (2012)

Studies toward the Development of Antiproliferative Neoclerodanes from Salvinorin A
por: Vasiljevik, Tamara, et al.
Publicado: (2014)

Hallucinations and Hallucinogens: Psychopathology or Wisdom?
por: Bouso, José Carlos, et al.
Publicado: (2023)

Brain mechanisms of hallucinogens and entactogens
por: Vollenweider, Franz X.
Publicado: (2001)

Kappa Opioids, Salvinorin A and Major Depressive Disorder
por: Taylor, George T., et al.
Publicado: (2016)

Salvinorin A Does Not Affect Seizure Threshold in Mice
por: Socała, Katarzyna, et al.
Publicado: (2020)

Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives
por: Martinotti, Giovanni, et al.
Publicado: (2018)

A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms
por: Chue, P., et al.
Publicado: (2022)

Psychedelic medicine and the clinical application of hallucinogens
por: eClinicalMedicine
Publicado: (2023)

Hallucinogenic and poisonous mushroom field guide /
por: Menser, Gary P.
Publicado: (1977)

Salvinorin A Inhibits Airway Hyperreactivity Induced by Ovalbumin Sensitization
por: Rossi, Antonietta, et al.
Publicado: (2017)

Hallucinogenic potential: a review of psychoplastogens for the treatment of opioid use disorder
por: Hornick, Mary G., et al.
Publicado: (2023)

Salvinorin A: A Mini Review of Physical and Chemical Properties Affecting Its Translation from Research to Clinical Applications in Humans
por: Orton, Edward, et al.
Publicado: (2014)

β(2)-Adrenergic Receptor Activation Suppresses the Rat Phenethylamine Hallucinogen-Induced Head Twitch Response: Hallucinogen-Induced Excitatory Post-synaptic Potentials as a Potential Substrate
por: Marek, Gerard J., et al.
Publicado: (2018)

Modulation of Social Cognition via Hallucinogens and “Entactogens”
por: Preller, Katrin H., et al.
Publicado: (2019)

Evaluation of Biased and Balanced Salvinorin A Analogs in Preclinical Models of Pain
por: Paton, Kelly F., et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects
por: Brito-da-Costa, Andreia Machado, et al.
Publicado: (2021)

The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges
por: dos Santos, Rafael Guimarães, et al.
Publicado: (2021)

Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans
por: Maqueda, Ana Elda, et al.
Publicado: (2016)

8-epi-Salvinorin B: crystal structure and affinity at the κ opioid receptor
por: Munro, Thomas A, et al.
Publicado: (2007)

Classical Hallucinogens As Antidepressant Drugs: A Cautionary Approach
por: dos Santos, Rafael G., et al.
Publicado: (2023)

Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy
por: dos Santos, Rafael G., et al.
Publicado: (2020)

Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe
por: Herian, Monika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r4m4nfo8ec2mkjg2c8f95tb9qg